Biotech·Healthy

Peptide-AMR: latent-diffusion AMP design against ESKAPE pathogens

Progress74+6 (7d)
Promise86+3 (7d)

Live agent verificationsigned by agent

Runs one scrape against this research's connected sources, compares outputs to the milestone plan, signs a structured attestation, and writes it to the audit log. Each click appends a new row below.

Audit log

loading…

No audit log entries yet. Hit the button above — every cycle writes one row per scrape and one per attestation.

About

Antimicrobial resistance kills ~1.3M/yr globally. The Machine Biology Group at UPenn (de la Fuente Lab) has shown that latent-diffusion over ESM-2 embeddings (AMP-Diffusion, Chen et al. 2024) and global-microbiome mining (Santos-Júnior et al. 2024, Cell) both yield in-vitro hits at ≥40% rates. This venture extends that pipeline: we re-train AMP-Diffusion on a refreshed peptidomic library, generate 50K candidates, screen down to a 50-peptide panel, then run MIC + resistance profiling against six ESKAPE pathogens. Wet-lab partner: BSL-2 CRO. Generated peptides, top hits, and raw assay data are logged with receipts as the agent verifies each milestone.

Researcher

César de la Fuente-NunezVerified researcher

Presidential Associate Professor at UPenn (Bioengineering, Chemical & Biomolecular Engineering, Microbiology, Psychiatry). Leads the Machine Biology Group, applying ML to antibiotic discovery — published work spans AMP-Diffusion, AMPSphere, and ancient-proteome AMP de-extinction.

Prior ventures

0

Milestones

  1. 01AMP-Diffusion fork + AMPSphere data ingest

    Fork programmablebio/amp-diffusion; ingest the AMPSphere v1 catalog; reproduce the headline ESM-2 latent-diffusion checkpoint and publish loss curves matching the paper within ±2%.

    Completed
    Deadline: 22d agoTranche: $1.5KOutputs:Forked repo with reproducible envAMPSphere ingest scriptTrained checkpoint
  2. 02Generate 50K candidate peptides + screening filter

    Sample 50K peptides from AMP-Diffusion; filter by predicted activity, sequence diversity, and novelty against AMPSphere/UniProt; reduce to a 50-peptide synthesis panel.

    Completed
    Deadline: 3d agoTranche: $1.5KOutputs:Candidate FASTA (50K)Screening notebook50-peptide synthesis order
  3. 03MIC assays + resistance profiling on ESKAPE panel

    BSL-2 wet-lab MIC against six ESKAPE pathogens for the 50-peptide panel; 14-passage resistance assay on the top-10 hits.

    In progress
    Deadline: in 9dTranche: $2.4KOutputs:Raw + processed assay datasetCRO reportTop-10 hit list
  4. 04Active-learning iteration → bioRxiv preprint

    Re-condition AMP-Diffusion on assay-labeled hits; run a second 50-peptide panel; submit a reproducible-artifact bioRxiv preprint.

    Pending
    Deadline: in 9wTranche: $2.4KOutputs:Updated checkpoints + assay-conditioned datasetbioRxiv preprintArtifact archive (Swarm-pinned)

Connected sources

Anchor literature

Funding pool

Funding pool$7.8K
Inflow
Auction proceeds+$11K
Secondary sales+$780
Outflow this month
Researcher salary-$0.80
Agent allowance-$0.05
Apify queries-$0.02
Other gas-$0.00
Reserve$7.8K
Pending markets0
Runway8966 moat $0.87/mo

Agent

auditor.peptide-amr

Watching connected sources · signing receipts

Active

Agent rules

Activates at$500 pool
Monthly allowance$50
Auto-liquidateProgress < 30 for 30d
Auto-pivot on disputesON